Weiqi, what's your experience from Taiwan?

Yeah, we did an epidemiology study a couple years ago, and we found out that since 2011, the use of anti-BGF suppressed the use of laser since then.

And right now, I think around 90% of the primary treatment was anti-BGF injection.

And laser was only 10%.

And this is a very interesting data compared to what we got from the US.

They are probably 50-50 at this point.

I think that maybe that reflects one thing is the anti-vision treated patient.

So the approach is to be different, and we still don't know what to do for the myopia prematurity.